Pliant Therapeutics, Inc.
PLRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $90,882 | $71,208 | $82,651 | $797,294 |
| - Cash | $93,732 | $86,820 | $91,936 | $71,188 |
| + Debt | $29,418 | $30,016 | $60,174 | $60,192 |
| Enterprise Value | $26,568 | $14,404 | $50,889 | $786,298 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$447 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$23,082 | -$42,044 | -$54,919 | -$48,440 |
| % Margin | – | – | – | – |
| Net Income | -$26,301 | -$43,300 | -$56,166 | -$49,732 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.43 | -0.71 | -0.92 | -0.82 |
| % Growth | 39.4% | 22.8% | -12.2% | – |
| Operating Cash Flow | -$21,081 | -$40,603 | -$48,864 | -$47,662 |
| Capital Expenditures | $0 | -$112 | -$262 | -$209 |
| Free Cash Flow | -$21,081 | -$40,715 | -$49,126 | -$47,871 |